Document Detail


Inadequate Therapeutic Response to a RecommendedAntituberculosis Fixed-Dose Combination Regimen in anOverweight Patient with Mycobacterium bovis Infection (January).
MedLine Citation:
PMID:  23324515     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE:To report a case of an overweight man with lymph node tuberculosis due to Mycobacterium bovis, a part of the Mycobacterium tuberculosis complex, treated with fixed-dose combination (FDC) chemotherapy.CASE REPORT:Following guidelines, according to the patient's weight (92 kg), we prescribed the maximum recommended doses of isoniazid-rifampin-pyrazinamide FDC. It led initially to underdosing, with a poor clinical outcome, justifying increased doses and a complex regimen using separate drugs (isoniazid 600 mg, rifampin 1200 mg, and levofloxacin 1000 mg) to achieve therapeutic drug concentrations and clinical response.DISCUSSION:Usually recommended doses of FDC chemotherapies may be inappropriate in overweight patients. We discuss here the different factors that may be involved in poor clinical outcomes, particularly the consequences of excess weight on drug metabolism: drug-drug interaction, FDC use, generic formulation use, intestinal malabsorption, and acetylation profile.CONCLUSIONS:Therapeutic drug monitoring in overweight patients may be useful in the clinical setting to help clinicians individualize drug therapeutic regimens and optimize drug response, adherence, and safety.
Authors:
Célia Lloret-Linares; Stéphane Mouly; Dan-Tranh Hoang-Nguyen; John Evans; Laurent Raskine; Amanda Lopes; Emmanuelle Cambau; Jean-François Bergmann; Pierre Sellier
Related Documents :
18093415 - Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit...
24304355 - Discovering and developing new medicines for malaria control and elimination.
24635555 - Topical delivery of ocular therapeutics: carrier systems and physical methods.
23059595 - Sublingual drug dispensing prosthesis.
19564145 - Development and evaluation of gastroretentive norfloxacin floating tablets.
17182025 - Pharmacodynamic monitoring of the immunosuppressive therapy in patients after heart tra...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-16
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  -     ISSN:  1542-6270     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
< Lariboisière Hospital, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antidepressant-Selective Gynecomastia (January).
Next Document:  The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medic...